'Deeply concerned' about impact of Covid-19 on global response to HIV: WHO

He stated that progress in reducing AIDS-related deaths can be "accelerated by stepping up efforts to tackle comorbidities and opportunistic infections including TB, Hepatitis and Covid-19"

WHO Director General Tedros Adhanom Ghebreyesus
WHO Director General Tedros Adhanom Ghebreyesus.
ANI
2 min read Last Updated : Jul 07 2020 | 8:00 AM IST
World Health Organisation (WHO) is deeply concerned about the impact of Covid-19 on the global response to HIV, its Director General Dr Tedros Adhanom Ghebreyesus has said.

"A new WHO survey showed access to HIV medicines has been significantly curtailed as a result of the pandemic. 73 countries have reported that they are at risk of stock-outs of antiretroviral medicines (ARVs)," the UN Health Body Chief said.

"To mitigate the impact of the pandemic on treatment access, WHO recommended that all countries prescribe ARVs for longer periods of time - up to six months while shoring up the supply chain for all medicines," said Tedros.

The WHO DG highlighted that in 2018 and 2019, the number of new HIV infections stabilised at 1.7 million annually and there was only a modest "progress in stalling because HIV prevention and testing services are not reaching the groups that need them most. "Improved targeting of proven prevention and testing interventions and services - including PrEP and HIV self-testing - will be critical to reinvigorating the global response to HIV," he said.

He stated that progress in reducing AIDS-related deaths can be "accelerated by stepping up efforts to tackle comorbidities and opportunistic infections including TB, Hepatitis and new threats like Covid-19".

"While tackling COVID-19 is a global priority we must not turn our backs on the 38 million people living with HIV and the millions more at risk of infection. Now is the time to redouble our efforts, build national unity and global solidarity to tackle both the COVID-19 pandemic and diseases like HIV," he said.

According to latest data from Johns Hopkins University, the number of coronavirus cases worldwide have exceeded 11.5 million while the death toll has surged past 5 lakh.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownWHOWorld Health Organisationhealthcare

Next Story